Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/Turkey/Turkey/05/133 (H5N2) Influenza Vaccine
Phase of Trial: Phase I
Latest Information Update: 30 Nov 2018
Price : $35 *
At a glance
- Drugs Influenza A virus vaccine H5N2 (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 30 Sep 2015 Results published in the Vaccine.
- 18 Aug 2015 Results published in the Vaccine.
- 06 Dec 2012 New trial record